2017-03-08 20:59:41 UTC

AGA and Crohn’s & Colitis Foundation Announce Conference Partnership

Inaugural Crohn’s & Colitis Congress for health-care professionals and researchers to take place in Las Vegas in January 2018.

Contact: Aimee Frank (AGA) 
media@gastro.org 
301-941-2620
Rebecca Kaplan (Crohn’s & Colitis Foundation)
646-943-7415


New York, NY (March 9, 2017) – The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) announced today that they are partnering to co-sponsor the first-ever “Crohn’s & Colitis Congress,” which will take place in Las Vegas in January 2018. 

The Crohn’s & Colitis Congress will be the premier conference for inflammatory bowel diseases (IBD) health-care professionals and researchers. It will bring state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.

“We are thrilled to be partnering with AGA, the nation’s premier gastroenterological professional organization on this new conference,” said Michael Osso, President & CEO of the Foundation. “By working together, we will bridge the patient and professional perspectives, and create a multidisciplinary, clinically-focused and forward-thinking experience for all attendees.” 

The new conference will focus on a comprehensive, patient-centered approach to IBD care, with sessions addressing the current realities and challenges in the disease space. The most advanced, cutting-edge research will be presented to assist the IBD community in providing the best quality of care to the 1.6 million Americans living with these diseases. 

”We are proud to be part of the Crohn’s & Colitis Foundation’s work to cure Crohn’s disease and ulcerative colitis,” said Tom Serena, executive vice president of AGA. “The Crohn’s & Colitis Congress will be 2018’s must-attend meeting for scientists and clinicians who want to accelerate advances in IBD patient care.” 

To plan the conference agenda, staff from the Foundation and AGA will work with an organizing committee comprised of leading health-care professionals representing the key disciplines involved in the comprehensive care of IBD as well as research.

###

About the Crohn’s & Colitis Foundation

The Crohn's & Colitis Foundation is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD. For more information visit www.crohnscolitisfoundation.org, call 888-694-8872, or email info@crohnscolitisfoundation.org.  

About the AGA

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org

 

More on Crohn's Disease

Crohn's & Colitis Congress™

Jan. 18, 2018

The Crohn's & Colitis Foundation and AGA are partnering on a new annual conference for health-care professionals and researchers. By joining the nation's leading IBD patient organization with the premier gastroenterological professional organization, this will be the must-attend IBD conference, bringing state-of-the-art comprehensive care together with the latest research to advance prevention, treatment and cures for IBD patients.

Principles of Gastroenterology for the NP and PA

Aug. 11, 2017

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

AGA Plans Education About IBD & Pregnancy

May 18, 2017

UCB provides support, research and education of health-care professionals and patients surrounding the issue.